Here we show that both The CFL1 and PGK1 expression can be used as prognosis factors for glioma patients (Figure 4), because both The CFL1 and PGK1 over-expression were associated with poor prognosis of radiotherapy cohort and entire followed-up cohort. The gene discussed is CFL1; the disease is glioma.